Drug trial looks to extend lives of people with advanced kidney cancer
He leads a trial at Upstate that offers patients a vaccine made just for them, designed to enlist their bodies‘ immune systems in the cancer fight. “The theory is that if we were to train the body‘s own immune system to recognize the cancerous cells, we could get a much more effective killing of the cancer cells,” he says.
Bratslavsky‘s trial is part of an international, multi-institutional study of patients with metastatic kidney cancer, or kidney cancer that has spread beyond the kidney. Patients who join the trial will undergo surgery, have their tumors analyzed, and then be placed in one of two groups. Both groups of patients will receive state-of-the-art therapy, and one group will also receive this new vaccine.
Upstate is one of the first sites in the United States to offer this trial -- along with the hope it provides for the patients.
Learn more by calling Upstate Urology at 315-464-1500.
Contact: Upstate Urology